Protalix BioTherapeutics, Inc. (PLX) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US74365A3095
Protalix BioTherapeutics, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 52.74 m USD |
| Gross profit | 25.75 m USD |
| Operating income | -5.50 m USD |
| EBIT | -5.61 m USD |
| Net income | -6.60 m USD |
| Diluted EPS – continuing operations | -0.08 USD |
Full history since 1996, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Protalix BioTherapeutics, Inc.
Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company provides Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell expressed recombinant PEGylated Uricase, which is in Phase 2 trial for the treatment of gout; and PRX-119, a plant cell expressed PEGylated recombinant human DNase I product candidate for the treatment of neutrophil extracellular traps diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. Protalix BioTherapeutics, Inc. has strategic partnership with Secarna Pharmaceuticals GmbH & Co KG. The company is headquartered in Hackensack. New Jersey.
More stocks
- FB Bancorp, Inc. /MD/ (FBLA)
- Bali Towerindo Sentra Tbk (BALI.JK)
- Ribbon Communications Inc. (RBBN)
- PURE CYCLE CORP (PCYO)
- Lanzhou Zhuangyuan Pasture Co Ltd (002910.SZ)
- Nuveen Core Plus Impact Fund (NPCT)
- Zhejiang Sanfer Electric Co. Ltd (605336.SS)
- VIA Labs Inc (6756.TW)
- Anhui Hyea Aromas Co Ltd (300886.SZ)
- Nano Dimension Ltd. (NNDM)
- Camp4 Therapeutics Corp (CAMP)
- NACCO INDUSTRIES INC (NC)
Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.